CD19 POSITIVE
Clinical trials for CD19 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CD19 POSITIVE trials appear
Sign up with your email to follow new studies for CD19 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Double-Target CAR-T cells tested in fight against tough blood cancers
Disease control OngoingThis early-stage study is testing the safety and best dose of a new type of CAR-T cell therapy designed to attack two common proteins (CD19 and CD20) found on certain blood cancer cells. The therapy involves collecting a patient's own immune cells, modifying them in a lab to reco…
Matched conditions: CD19 POSITIVE
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New immune therapy trial aims to target tough leukemia
Disease control OngoingThis early-stage study is testing the safety and side effects of a new type of immune cell therapy for adults with B-cell acute lymphoblastic leukemia that has come back or hasn't responded to other treatments. The therapy involves genetically modifying a patient's own immune cel…
Matched conditions: CD19 POSITIVE
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC